Risks and benefits of asthma therapies
Maintenance use of short-acting adrenergic agents can cause tachyphylaxis, increased non-specific bronchial hyperreactivity, poorer clinical control, a worsened late allergic reaction and possibly an increased risk of death; therefore, 'as needed' use is preferable. The choice of a first l...
Main Author: | Peter König |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2000-01-01
|
Series: | Allergology International |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1323893015313800 |
Similar Items
-
EXERCISE-INDUCED ASTHMA: FRESH INSIGHTS AND AN OVERVIEW
by: KHAJOTIA R
Published: (2008-01-01) -
Tacrolimus eye drops as monotherapy for vernal keratoconjunctivitis: a randomized controlled trial
by: Eduardo Gayger Müller, et al. -
Formulation and optimization of nano-sized ethosomes for enhanced transdermal delivery of cromolyn sodium
by: R Rakesh, et al.
Published: (2012-01-01) -
Development of non-steroidal anti-inflammatory drug intolerance over a 3 year period
by: Toshihiro Shirai, et al.
Published: (2004-01-01) -
Comparison of Preoperative Topical Dexamethasone Phosphate Versus Ketorolac Tromethamine in Maintaining Intraoperative Mydriasis During Small Incision Cataract Surgery
by: Ashok Kumar Sharma, et al.
Published: (2016-05-01)